use in Medical Technology

NewCardio Announces Master Services Agreement With Dedicated Phase I

... Dedicated Phase I will receive a license to use NewCardio's QTinno(TM) software solution in all ... demonstrates the firm's commitment to the use of technology to improve quality and efficiency." ... made possible for the first time through the use of NewCardio's QTinno(TM) solution. ...

TWO NEW KLRI PEER-REVIEWED PUBLICATIONS: Hormone Therapy May Reduce Atherosclerosis in Women Close to Menopause; Growth Hormone May Increase Risk of Diabetes, Improve Lipid Profile in Men

... Association and other groups began menopausal HT use much later than in usual clinical ... (the body's inability to respond to and use the insulin it produces) to increase, yet it had ... childhood and maintain tissues and organs. Their use as an anti-aging therapy stems from the natural ...

Estrogen Getting Cool Reception From Dermatologists for Mixed Results in Improving Appearance of Skin

... of the lack of consistent data to support their use and the known risks of prolonged estrogen therapy ... effective therapies that dermatologists regularly use to address the common signs of aging -- including ... factor (SPF) of at least 30, don't smoke and use a topical retinoid," said Dr. Parsons. "When it ...

First Skin Cancer Patients Treated With Electronic Brachytherapy (eBx) At University of Wisconsin Riverview Cancer Center

... to administer radiation therapy without the use of a radioactive isotope and in clinical settings ... the Axxent eBx System is also FDA cleared for use in the treatment of surface cancers or conditions ... Brachytherapy System is also cleared for use in the treatment of other cancers or conditions ...

Schering-Plough Announces U.S. Filing of Mometasone Furoate/Formoterol Fumarate Combination for the Maintenance Treatment of Asthma

... in patients younger than 12 years of age and for use in COPD is currently in Phase III development. ... not be used to treat sudden asthma symptoms. use a rescue inhaler to relieve sudden asthma ... throat tightness reported. Patients who use inhaled steroid medicines for asthma may develop ...

BioCryst Pharmaceuticals Reports Positive Results of Shionogi & Co. Sponsored Phase 3 Studies of i.v. Peramivir for Influenza

... while continuing to support the pre-emergency use authorization review of peramivir by the U.S. ... peramivir is currently undergoing a pre-emergency use authorization (EUA) review. About the ... include: that peramivir may not receive emergency use authorization; that the U.S. government may ...

Schering-Plough Expands Vicriviroc Phase II Study in Treatment-Naive Patients With HIV

... its investigational CCR5 antagonist, for use in first-line therapy of adult treatment-naive ... therapy. The combinations characteristically use two NRTIs with either a non-nucleoside reverse ... Atazanavir boosted by ritonavir was selected for use in this study because it is recommended as an ...

ASMANEX(R) (Mometasone Furoate Dry Powder Inhaler) Now Approved in Japan for the Treatment of Bronchial Asthma in Adult Patients

... shown improvement in lung function, decreased use of rescue medication, and improvement in daytime ... not be used to treat sudden asthma symptoms. use a rescue inhaler to relieve sudden asthma ... and throat tightness reported. Patients who use inhaled steroid medicines for asthma may develop ...

June 2009 Mayo Clinic Women's HealthSource Highlights Summer Skin Problems, Low Vision and Pilates

... specialist to determine the best tools and how to use them. In many cases, patients will find vision ... with the eyeglasses or attached to a headband for use on close-up tasks such as reading or threading a ... across the room. Video magnifiers. They use a camera and a video screen to enlarge printed ...

New AHRQ Study Finds Mixed Evidence on Use of Radiofrequency Catheter Ablation for Treating Atrial Fibrillation

... and Quality. The report examines the use of a procedure called radiofrequency catheter ... the first two ablation catheters indicated for use in treating atrial fibrillation, in the United States. However, physicians often use other catheters that have not been approved by ...

Cephalon Submits NUVIGIL Supplemental New Drug Application for the Treatment of Excessive Sleepiness Associated with Jet Lag Disorder

... "This supplemental New Drug Application for a new use of NUVIGIL is another important milestone for ... in NUVIGIL). NUVIGIL is not approved for use in pediatric patients for any indication. ... some of these forward-looking statements by the use of words in the statements such as "anticipate," ...

SIMPONI(TM) (golimumab) Receives Positive Opinion From CHMP for Once-Monthly Subcutaneous Treatment of Rheumatoid Arthritis, Psoriatic Arthritis and Ankylosing Spondylitis

... the Committee for Medicinal Products for Human use (CHMP) of the European Medicines Agency (EMEA) ... infections have been observed with the use of TNF antagonists including SIMPONI. Some of ... Caution should be exercised when considering the use of SIMPONI in patients with a chronic infection ...

Acute Lymphoblastic Leukemia, the Most Common Childhood Cancer, Is Curable Without Preventive Cranial Radiation

... chemotherapy can improve cure rate and avoid the use of radiation in acute lymphoblastic leukemia ... imbalances and cognitive deficits. Optimized use of anticancer drugs, especially those instilled ... can be safely eliminated in all patients with the use of highly effective chemotherapy regimens. The ...

Spherix Announces Positive Phase 2 Study Results

... Naturlose Spherix holds patents on the use of Naturlose as a drug to treat diabetes. ... 10 years of animal, human, and other relevant use and safety data, Naturlose was determined to be Generally Recognized As Safe (GRAS) for use in foods as regulated by the Food Additives ...

Cordex Signs European Development Partnership for ATPotent(TM) Sperm Motility Drug

... Cordex's proprietary technologies related to the use of adenosine 5'-triphosphate (ATP) for improving ... of heart failure, the expected results of the use of ATPace(TM) and the estimated PSVT market. The ... commercialization of technologies relating to the use of ATP or nitric oxide. Additional uncertainties ...

Study Results Present Efficacy and Safety Findings from the PHIRST-1 Study of Patients with Pulmonary Arterial Hypertension Taking Tadalafil Tablets Once Daily

... their physician before starting ADCIRCA. The use of ADCIRCA with alpha blockers, blood pressure ... alcohol may cause a lowering of blood pressure. use of ADCIRCA with potent CYP3A inhibitors, such as ... or those taking the drug ritonavir should use a dose of 20 mg daily when beginning therapy with ...

Meta-Analysis of Clinical Data Showed No Increased Risk of Cardiovascular Events Associated With Exenatide Use: Data Presented at ADA 2009

... associated with BYETTA(R) (exenatide) injection use compared to a pooled comparator group treated ... and brain. BYETTA is approved by the FDA for use by people with type 2 diabetes who are ... insulin treatment. BYETTA is not recommended for use in patients with severe problems digesting food ...

Exenatide Once Weekly Provided Sustained Improvements in Glycemic Control With Weight Loss Over Two Years: DURATION-1 Interim Long-Term Data Presented at ADA 2009

... and brain. BYETTA is approved by the FDA for use by people with type 2 diabetes who are ... insulin treatment. BYETTA is not recommended for use in patients with severe problems digesting food ... These are not all of the side effects from use of BYETTA. A healthcare provider should be ...

Studies Show AFRESA(R) Controls Post-Meal Sugar Levels With Less Weight Gain and Hypoglycemia Risk for Diabetes Patients

... Inhalation Powder and the AFRESA Inhaler for use in adult patients with type 1 and type 2 diabetes ... acting mealtime insulin therapy being studied for use in adult patients with type 1 and type 2 diabetes ... AFRESA Inhalation Powder pre-metered into single use dose cartridges and the light, discreet and easy ...

AFRESA(R) Phase 3 Pulmonary Function Safety Data in Patients with Diabetes Presented at ADA

... Inhalation Powder and the AFRESA Inhaler for use in adult patients with type 1 and type 2 diabetes ... acting mealtime insulin therapy being studied for use in adult patients with type 1 and type 2 diabetes ... AFRESA Inhalation Powder pre-metered into single use dose cartridges and the light, discreet and easy ...

PharmAthene Submits Proposal to BARDA in Response to Broad Agency Announcement for Advanced Research and Development for Valortim(R)

... for acquisition into the SNS for potential use under an Emergency use Authorization (EUA), and for submission of a ... drugs available for therapeutic or prophylactic use for inhalation anthrax, and post-exposure ...

Neurobiological Technologies' Partner, Celtic Pharma, Announces Results of XERECEPT(R) Phase 3 Clinical Program

... significant reductions in corticosteroid use in patients with cerebral edema associated with ... of XERECEPT(R). "The ability to reduce the use of steroids and concomitant reduction in adverse ... both in terms of lowering dexamethasone use over the longer-term and the impact seen in ...

TNFerade(TM) Phase III Data Presented at ASCO

... and Drug Administration (FDA) for its proposed use in the treatment of locally advanced pancreatic cancer. GenVec is developing TNFerade for use in combination with radiation and/or chemotherapy ... is currently being evaluated for its potential use in the treatment of several other cancers, ...

Three Independent Studies Include the ImmuKnow(R) Assay to Manage and Optimize Immunosuppression Therapy in Transplant Patients

... transplant recipients to determine whether the use of the ImmuKnow assay to guide immunosuppression ... it did not reach statistical significance, the use of the ImmuKnow assay resulted in substantially ... Ohio State University prospectively studied the use of the ImmuKnow assay together with various viral ...

Bayer Announces Leukine(R) Data Presentations at 45th American Society of Clinical Oncology (ASCO) Annual Meeting

... announced that several studies evaluating the use of Leukine(R) (sargramostim) will be presented at ... Budget impact analysis of sargramostim use in patients with chemotherapy-induced neutropenia ... the only growth factor approved in the U.S. for use following induction chemotherapy in older adults ...

Perceptive Informatics Enhances Investigator Application of New RECIST Version in Imaging-Based Oncology Trials

... as well as instructions on how to effectively use the new criteria. Medical imaging experts ... and regulatory solutions to improve the use of medical imaging as a surrogate endpoint in ... or progression of disease in solid tumors use RECIST. The new version of RECIST will provide a ...

Catalyst Pharmaceutical Partners Announces Top-Line Results of CPP-109 Phase II Trial for Cocaine Addiction

... our view that CPP-109 has the potential for use in treating cocaine addiction, which still ... which will provide us with data that we can use to assess the next steps in our strategy." ... in the United States relating to the right to use vigabatrin to treat a wide variety of substance ...

FDA Advisory Panel Recommends Approval of the SEDASYS(R) System

... Panel Votes in Favor of use by Physician/Nurse Teams to Deliver ... in favor of approval of the SEDASYS(R) System for use by physician/nurse teams to administer ... device limited by U.S. law to investigational use only. About Ethicon Endo-Surgery Ethicon ...

Video: Data on More Than 15 Novartis Oncology Compounds at ASCO Highlight Progress Toward Targeted Therapies for Diverse Tumor Types

... patients These data support the use of HSP70 as a biomarker for HSP90 inhibition. ... tumor cell survival and division, through the use of AUY922, resulted in an up regulation/increase ... with Femara. Until you know how it affects you, use caution before driving or operating machinery. ...

Fate Therapeutics Announces First Patient Treated in Phase 1b Clinical Trial of FT1050 for Hematopoietic Stem Cell Support

... adult donors, the ability to increase cord blood use by enhancing its efficiency has the potential to ... therapy with HSC support and will use two human umbilical cord blood (CB) units as the ... stem cell support. About Cord Blood use in Hematopoietic Stem Cell Support Human ...

Scientific Data Relating to Cinryze(TM) Presented at 6th Annual C1 Inhibitor Deficiency Workshop

... data of Cinryze. One trial examined the use of C1-INH for the treatment of acute attacks of ... nanofiltration. Cinryze is for intravenous use only. A dose of 1000 Units of Cinryze can be ... testing. The FDA may view the data regarding the use of Cinryze for acute treatment of HAE we have ...

New Phase 3 Study of Tapentadol Immediate Release Tablets Published in Current Medical Research and Opinion Journal

... side effects, such as nausea and vomiting. The use of opioid pain medicines during and after surgery ... of the double-blind treatment period. The allowed use of acetaminophen was intended to improve ... serotonin syndrome may occur with use of SNRI products, including NUCYNTA(TM), ...

FDA Approves ADCIRCA(TM) (Tadalafil) Tablets for the Treatment of Pulmonary Arterial Hypertension

... their physician before starting ADCIRCA. The use of ADCIRCA with alpha blockers, blood pressure ... alcohol may cause a lowering of blood pressure. use of ADCIRCA with potent CYP3A inhibitors, such as ... or those taking the drug ritonavir should use a dose of 20 mg daily when beginning therapy with ...

RISPERDAL(R) CONSTA(R) (Risperidone) Long-Acting Treatment Delayed the Time to Relapse in Patients with Bipolar I Disorder

... lasting erections have been reported with the use of RISPERDAL(R) CONSTA(R). Call your doctor ... fatal symptom complex, has been reported with the use of antipsychotic medications, including ... Esophageal dysmotility and aspiration can occur. use cautiously in patients at risk for aspiration ...

Video: Partnership Unites UCB with Consumer Product Innovator OXO(R)

... from the partnership with OXO(R) was designed for use by patients with different grip styles and ... the prefilled syringe, which is available for use with Cimzia(R), is designed with the following in ... and clear visuals instruct patients how to use the pack and administer/inject Cimzia(R); and ...

Cadence Pharmaceuticals Submits Acetavance New Drug Application for the Treatment of Acute Pain and Fever

... States is the NSAID, ketorolac. Post-operative use of intravenous ketorolac is limited due to its ... events further limit the post-operative use of NSAIDs. Dipyrone (metamizole) was the last ... proprietary product candidates principally for use in the hospital setting. The company is currently ...

ValueOptions(R) Supports New Hospital-Based Performance Measures to Help Patients Get the Best Treatment for Inpatient and Outpatient Services

... wellness company, announces its support for the use of The Joint Commission's Hospital-Based ... measures are now available for widespread use in hospitals. (Logo: ... strengths Hours of physical restraint use Hours of ...

Ongoing Landmark ROADMAP Study Demonstrates Significant Improvement in Blood Pressure Control at One Year, According to Blinded Results

... IMPORTANT SAFETY INFORMATION ABOUT BENICAR use IN PREGNANCY When used in pregnancy during ... have been reported. There has been no long-term use of olmesartan medoxomil in patients with ... medical supervision and consideration given to use of a lower starting dose *Creatinine ...

New Data Shows Blood Pressure Reduction Therapy with BENICAR(R) and BENICAR HCT(R) Effectively Reduces Blood Pressure in Elderly Patients to Target Blood Pressure

... "Although some physicians may be reluctant to use aggressive treatments for fear of an increased ... ABOUT BENICAR (R) and BENICAR HCT (R) use IN PREGNANCY When used in pregnancy during ... have been reported. There has been no long-term use of olmesartan medoxomil in patients with ...

BioCryst Provides Peramivir Update and Reports First Quarter 2009 Financial Results

... peramivir is currently undergoing a pre-emergency use authorization (EUA) review. Government agencies ... continues to expect the Company's net cash use in 2009 will be between $30.0 and $38.0 million, ... include: that peramivir may not receive emergency use authorization; that the U.S. government may ...